Full Name
                                                    Dr. Chris Schumpp
                                                    Job Title
                                                    Specialty pharmacist, oncology
                                                    Practice/Company Name
                                                    University of Illinois Cancer Center
                                                    Speaker Bio
                                                    Chris Schumpp, PharmD, is a clinical pharmacist for the University of Illinois Cancer Center and the Specialty Pharmacy Oncology Pharmacist for UI Health Specialty Pharmacy Services. He earned a Bachelor’s in chemistry from Loyola University Chicago and a PharmD from the University of Illinois at Chicago’s College of Pharmacy. He completed a Specialty Pharmacy residency at the University of Illinois at Chicago.  
As the Specialty Pharmacy Oncology Pharmacist for UI Health Specialty Pharmacy Services, Chris provides initial and ongoing education for patients treated with oral anticancer agents and is a resource for patients and the medical team at the University of Illinois Cancer Center. Chris has been a member of NCODA since 2017 and is an active member of the OCE committee. Additionally, because University of Illinois Cancer Center was a beta test site for NCODA’s Treatment Support Kits, Chris was involved with field testing TSKs with his patients.
                                                    As the Specialty Pharmacy Oncology Pharmacist for UI Health Specialty Pharmacy Services, Chris provides initial and ongoing education for patients treated with oral anticancer agents and is a resource for patients and the medical team at the University of Illinois Cancer Center. Chris has been a member of NCODA since 2017 and is an active member of the OCE committee. Additionally, because University of Illinois Cancer Center was a beta test site for NCODA’s Treatment Support Kits, Chris was involved with field testing TSKs with his patients.
Speaking At
                                                    
                        